19 medicines in Sweden are under investigation in a major EMA inquiry
19 medicines marketed in Sweden are affected by an ongoing extensive European investigation into suspected fraud at an Indian contract research organisation. Among them are medicines for HIV, epilepsy, cancer and Parkinson’s, which may be withdrawn unless new evidence can be provided that they are up to standard.
Posaconazole Stada Erlotinib Sandoz Erlotinib Stada Lacosamide Stada Darunavir Sandoz Darunavir Stada
Source: lifesciencesweden.se